Zealand’s dasiglucagon meets key endpoints in paediatric trial of severe hypoglycaemia
Invented and developed by Zealand Pharma, dasiglucagon is a potential first-in-class soluble glucagon analogue with a unique stability profile in a ready-to-use aqueous solution. Dasiglucagon is being developed